Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1148 participants.

Also called NCT06486792

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,148 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06486792
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06486792. Randomized; single masking; primary purpose treatment. Start 2025-06-18 (actual); primary completion 2028-12-18 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation
Acronym
SPICAF
Condition
Stroke
Condition
Cerebral Infarction
Intervention (Drug)
Apixaban
Intervention (Drug)
Aspirin
Lead sponsor
Assistance Publique - Hôpitaux de Paris (class: other)

Record details

Record id
cardio:ct-nct06486792
Content hash
df6b33fbb17f03d8326554c6bd714ead02a4f0e8252026d5fe234ee02ad557a0